Dyne Therapeutics Files 8-K on Security Holder Votes
Ticker: DYN · Form: 8-K · Filed: Jun 5, 2025 · CIK: 1818794
| Field | Detail |
|---|---|
| Company | Dyne Therapeutics, INC. (DYN) |
| Form Type | 8-K |
| Filed Date | Jun 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
DYNE filed an 8-K for shareholder votes - standard procedure, no new info yet.
AI Summary
Dyne Therapeutics, Inc. filed an 8-K on May 30, 2025, to report on the submission of matters to a vote of its security holders. The filing does not detail the specific matters or the outcome of any votes, but it is a standard procedural filing.
Why It Matters
This filing indicates that Dyne Therapeutics is engaging with its shareholders on important corporate decisions, which is a key aspect of corporate governance.
Risk Assessment
Risk Level: low — This is a routine procedural filing related to corporate governance and does not contain new financial or operational information that would typically impact stock price.
Key Players & Entities
- Dyne Therapeutics, Inc. (company) — Registrant
- May 30, 2025 (date) — Date of earliest event reported
- 1560 Trapelo Road Waltham, Massachusetts 02451 (address) — Principal Executive Offices
- (781) 786-8230 (phone_number) — Registrant's telephone number
FAQ
What specific matters were submitted for a vote of Dyne Therapeutics' security holders?
The filing does not specify the exact matters submitted for a vote, only that such matters were submitted.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on May 30, 2025.
What is the principal executive office address for Dyne Therapeutics, Inc.?
The principal executive office is located at 1560 Trapelo Road, Waltham, Massachusetts 02451.
What is the telephone number for Dyne Therapeutics, Inc.?
The telephone number is (781) 786-8230.
Under which section of the Securities Exchange Act is this 8-K report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 5, 2025 regarding Dyne Therapeutics, Inc. (DYN).